Lupus Unlocked: Journal Club

In this first webinar of RheumNow's Lupus Unlocked campaign, Journal Club discussed two articles: 

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. Furie R, et al. NEJM. 2025 Feb 7. doi: 10.1056 

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1) Rovin BH. Lancet. 2021 May 29;397(10289) 

Speakers: Brad Rovin, MD Richard Furie, MD Jack Cush, MD

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×